Table 1. Patient demographics and distribution of clinical phenotype clusters.
| N (%) | ||
|---|---|---|
| Positive serology | Yes | 117 (32.3) |
| No | 245 (67.7) | |
| Sex | Male | 143 (33.8) |
| Female | 219 (67.2) | |
| Meningoencephalitis symptoms—any (ME-any) | Yes | 162 (44.6) |
| No | 201 (55.4) | |
| Meningoencephalitis—3 or more symptoms (ME3) | Yes | 30 (8.3) |
| No | 333 (91.7) | |
| Hemorrhagic fever symptoms—any (HE-any) | Yes | 34 (9.4) |
| No | 329 (74.1) | |
| Hemorrhagic fever—3 or more symptoms (HE3) | Yes | 4 (1.1) |
| No | 359 (98.9) | |
| RVFV eye disease symptoms—any (any_eye) | Yes | 140 (38.6) |
| No | 223 (50.2) | |
| RVFV eye disease—2 or more symptoms (eye2) | Yes | 107 (29.5) |
| No | 256 (57.7) | |
| RVFV non-specific symptoms (nonspec_any) | Yes | 318 (71.6) |
| No | 45 (12.4) | |
| RVFV non-specific—3 or more symptoms (nonspec3) | Yes | 159 (35.8) |
| No | 204 (56.2) | |
| Any symptoms (any) | Yes | 323 (89.0) |
| No | 40 (11.0) | |
| Any 3 or more symptoms (any3) | Yes | 207 (46.6) |
| No | 156 (43.0) | |
| Symptom severity clusters: | Severe = 1 | 45 (38.5) |
| Moderate = 2 | 44 (37.6) | |
| Mild = 3 | 28 (24) |